Article: article from journal or magazin.
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
La corticothérapie systémique en rhumatologie, avantages et risques. [Systemic corticosteroid therapy in rheumatology, advantages and risks]
Schweizerische Rundschau fur Medizin Praxis
English Abstract Journal Article Review --- Old month value: Aug 12
Apart from the therapy of autoimmune diseases, corticosteroids have an important position in the treatment of rheumatoid arthritis. Corticosteroids are used after the failure of non-steroidal antiinflammatory agents or of the basis therapies to control the illness. When the rheumatoid arthritis is accompanied by a systemic disease, they will be used earlier and in higher dosages. For polymyalgia rheumatica, independently of an association with temporal arteritis, corticosteroids are the therapy of choice. Risks of long-time corticosteroid therapy are a higher incidence of infection and bone demineralisation, especially in postmenopausal women. A careful prevention with Calcium and Vitamin D must be carried out systematically. The demineralisation can be limited by the use of Deflazacort, a corticosteroid, which decreases the loss of calcium.
Adolescent Adrenal Cortex Hormones/adverse effects/*therapeutic use Adult Anti-Inflammatory Agents/adverse effects/*therapeutic use Arthritis, Rheumatoid/*drug therapy Bone Density/drug effects Child Child, Preschool Dose-Response Relationship, Drug Female Humans Male Steroids
Last modification date